Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



New Products

Related to Immune Response Markers for Cancer Vaccines

    • Heterodimer Immunoassay Kit
    • Singulex
    • The Erenna® Interleuken-17A/F (IL-17A/F) heterodimer immunoassay kit is an addition to a suite of TH17 pathway bioassays which also includes IL-17A and IL-17F as well as several others. These biomarkers are members of the IL-17 signaling pathw
    • Sequencing Assays
    • Roche
    • GS GType TET2/CBL/KRAS and the GS GType RUNX1 primer sets are designed for comprehensive genetic variation detection in four key human genes using the 454 GS Junior and GS FLX Systems. The sequence-based assays offer a solution for cancer researche
    • Knockout Cell Lines for Cancer Research
    • Cellectis bioresearch
    • The cells in CanCELL™ cell lines represent comprehensive knockouts of major disease-relevant oncogenes and tumor suppressor genes. CanCELL cell lines are generated using TALEN™ technology and offer opportunities to study signaling pathways and gene
    • Transfection Reagent
    • Mirus Bio
    • TransIT®-BrCa transfection reagent is a dedicated breast cancer cell-line specific reagent that can help researchers achieve high expression levels in breast cancer cell types including MCF-7, MDA-MB-231, MDA-MB-453, MDA-MB-468, and T47D. It c
    • Protein Biomarker Immunoassays
    • Olink Bioscience
    • Proseek® Multiplex is a generation of multiplexed protein biomarker immunoassays based on the Proximity Extension Assay (PEA) platform. Proseek Multiplex allows biomarker researchers to quantify 92 proteins in one microliter sample against a p
    • Tumor Marker Control
    • Randox Laboratories
    • The Acusera multianalyte liquid tumor marker control covers a total of 15 commonly tested and esoteric cancer antigens and tumor markers. Assayed target values can help laboratories monitor both accuracy and precision. The liquid stable nature redu
    • DNA Reference Standard
    • Horizon Discovery
    • The Quantitative Multiplex DNA reference standard is intended for researchers assessing multiple biomarkers in a single assay using platforms such as next-generation sequencing. It can enable researchers to quantify a range of detection thresholds
  • Page 1 of 1 (7 items) 1 

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll